BANK OF MONTREAL /CAN/ - KEROS THERAPEUTICS INC ownership

KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 81 filers reported holding KEROS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of KEROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$933,334
+177.8%
19,400
+67.1%
0.00%
Q2 2022$336,000
+1244.0%
11,613
+2870.1%
0.00%
Q1 2021$25,000
-82.5%
391
-80.7%
0.00%
Q4 2020$143,000
+1091.7%
2,027
+529.5%
0.00%
Q3 2020$12,000
-36.8%
322
-42.2%
0.00%
Q2 2020$19,0005570.00%
Other shareholders
KEROS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CHI Advisors LLC 407,633$12,995,3405.15%
Opaleye Management Inc. 360,400$11,489,5523.74%
Parkman Healthcare Partners LLC 298,475$9,515,3831.74%
BRAIDWELL LP 1,357,309$43,271,0111.37%
First Light Asset Management, LLC 421,438$13,435,4431.28%
Orbimed Advisors 1,514,734$48,289,7201.03%
Yiheng Capital Management, L.P. 554,151$17,666,3340.90%
Nantahala Capital Management 328,781$10,481,5380.90%
DAFNA Capital Management LLC 65,961$2,102,8370.65%
EDBI Pte Ltd 10,105$322,1470.35%
View complete list of KEROS THERAPEUTICS INC shareholders